Macrogenics MGNX
NASDAQ MGNX
$4.39 +0.14 (+3.41%)
As of: Sep 4, 2026 · 3:15 PM EDT

Macrogenics (MGNX) Receivables - Net (2012 - 2026)

Macrogenics (MGNX) posted quarterly Receivables - Net of $10.4 million for Q1 2026, down 1.12% year-over-year from $10.5 million in Q1 2025, and down 22.04% quarter-over-quarter from $13.4 million in Q4 2025.

Analysis

Macrogenics (MGNX) Receivables - Net (2012 - 2026) Analysis & Trends

Macrogenics (MGNX) has reported Receivables - Net for 15 consecutive years, with $10.4 million the latest figure, recorded in Q1 2026.

  • In Q1 2026, Receivables - Net fell 1.12% year-over-year to $10.4 million; the TTM figure through Mar 2026 stood at $10.4 million (down 1.12% YoY), while the FY2025 annual figure was $13.4 million, up 210.35% from the prior year.
  • Receivables - Net declined to $10.4 million in Q1 2026 per MGNX's latest filing, from $13.4 million in the prior quarter.
  • Across five years, Receivables - Net topped out at $69.2 million in Q3 2025 and bottomed at $4.3 million in Q4 2024.
  • Historically, Receivables - Net has averaged $19.1 million across 5 years, with a median of $12.5 million in 2025.
  • Annual changes were most pronounced in 2023 — Receivables - Net plunged 81.56% — and 2025, when it jumped 691.2%.
  • Macrogenics' Receivables - Net stood at $56.2 million in 2022, then slumped by 81.56% to $10.4 million in 2023, then tumbled by 58.44% to $4.3 million in 2024, then surged by 210.35% to $13.4 million in 2025, then decreased by 22.04% to $10.4 million in 2026.
  • Business Quant data shows MGNX's Receivables - Net at $10.4 million in Q1 2026, $13.4 million in Q4 2025, and $69.2 million in Q3 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.51 Bn 130.66 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.24 Bn 77.25 Bn 3.93 Bn
3 Argenx Se 63.46 Bn 58.28 Bn 1.37 Bn
4 Moderna 57.89 Bn 52.75 Bn 52.00 Mn
5 Revolution Medicines 44.02 Bn 44.02 Bn -
6 BeOne Medicines 39.95 Bn 34.85 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.49 Bn 32.19 Bn 992.69 Mn
8 Royalty Pharma 28.43 Bn 27.59 Bn -
9 Insmed 27.39 Bn 26.22 Bn 358.27 Mn
10 Macrogenics 279.50 Mn 165.59 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 24.60 Mn
Mar 31, 2026 10.43 Mn
Dec 31, 2025 427,000.00
Sep 30, 2025 69.23 Mn
Jun 30, 2025 12.53 Mn
Mar 31, 2025 10.54 Mn
Dec 31, 2024 4.31 Mn
Sep 30, 2024 8.75 Mn
Jun 30, 2024 6.19 Mn
Mar 31, 2024 7.22 Mn
Dec 31, 2023 10.37 Mn
Sep 30, 2023 25.31 Mn
Jun 30, 2023 6.41 Mn
Mar 31, 2023 36.16 Mn
Dec 31, 2022 56.22 Mn
Sep 30, 2022 13.84 Mn
Jun 30, 2022 18.39 Mn
Mar 31, 2022 14.91 Mn
Dec 31, 2021 10.39 Mn
Sep 30, 2021 13.76 Mn